Clinical Trial Update: An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing efficacy, safety, and pharmacokinetics of NBI-1117568 in adults with Bipolar I Disorder experiencing mania; recruitment ongoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Mania

Drugs mentioned

• NBI-1117568

Snippet

Sponsor: Neurocrine Biosciences | Conditions: Bipolar I Disorder, Mania | Phase 2 | Status: RECRUITING